NCT02303821 2025-06-04Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic LeukemiaAmgenPhase 1 Completed141 enrolled 37 charts
NCT01564784 2019-01-09A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic LeukemiaPfizerPhase 3 Completed326 enrolled 33 charts 1 FDA
NCT00562965 2018-01-09Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)PfizerPhase 3 Terminated29 enrolled 14 charts
NCT01144403 2016-10-18A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma.Hoffmann-La RochePhase 2 Terminated8 enrolled 9 charts
NCT00002003 2005-06-24Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic LymphomasNIH AIDS Clinical Trials Information ServicePhase 2 Completed